24.7% industrial tunnel oxide passivated contact solar cells prepared through tube PECVD integrating with plasma-assisted oxygen oxidation and in-situ doped polysilicon
Solar Energy Materials and Solar Cells · 2023-08 · 257 · 112396
DOI: 10.1016/j.solmat.2023.112396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Solar Energy Materials and Solar Cells, 2023-08. Verfasst von S. Ma und 8 weiteren Autor:innen. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Science and Technology Major Project of Inner Mongolia, Major State Basic Research Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Science and Technology Major Project of Inner Mongolia
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ma, S., Liao, B., Qiao, F., Ding, D., Gao, C., Li, Z., Tong, R., Kong, X., & Shen, W. (2023). 24.7% industrial tunnel oxide passivated contact solar cells prepared through tube PECVD integrating with plasma-assisted oxygen oxidation and in-situ doped polysilicon. Solar Energy Materials and Solar Cells, 257, 112396. https://doi.org/10.1016/j.solmat.2023.112396
Vancouver
Ma S, Liao B, Qiao F, Ding D, Gao C, Li Z, et al. 24.7% industrial tunnel oxide passivated contact solar cells prepared through tube PECVD integrating with plasma-assisted oxygen oxidation and in-situ doped polysilicon. Solar Energy Materials and Solar Cells. 2023;257:112396. doi:10.1016/j.solmat.2023.112396
BibTeX
@article{Ma2023,
author = {Ma, S. and Liao, B. and Qiao, F.Y. and Ding, D. and Gao, C. and Li, Z.P. and Tong, R. and Kong, X.Y. and Shen, W.Z.},
title = {24.7% industrial tunnel oxide passivated contact solar cells prepared through tube PECVD integrating with plasma-assisted oxygen oxidation and in-situ doped polysilicon},
journal = {Solar Energy Materials and Solar Cells},
year = {2023},
volume = {257},
pages = {112396},
doi = {10.1016/j.solmat.2023.112396}
}
EUVIMED